MAPT and Alzheimer disease: Most important, there is not convincing evidence for a specific association between disturbed SWS in humans and accumulation of AD biomarkers such as Aβ and tau from neither experimental nor observational studies (Kimura and others 2023; Sangalli and Boggero 2023; see Box 2 for a background on CSF biomarkers for AD).